Speech Therapy Practice EBITDA Multiples: 3.5x–6.0x — What Buyers Pay (2026)
How buyers price SLP clinics in the $1M–$5M revenue range — and what moves the multiple up or down.
Speech therapy practices in the lower middle market typically trade at 3.5x–6x EBITDA, reflecting strong demand from PE-backed therapy roll-ups and SBA-financed SLP buyers. Valuation hinges on owner independence, payer mix diversification, staff depth, and referral source durability. Practices with recurring school district contracts, low founder clinical involvement, and employed SLP teams command premium multiples, while Medicaid-heavy or founder-dependent clinics face meaningful discounts.
Speech Therapy Practice EBITDA Multiples (2026)
| Practice Size | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed / Founder-Dependent | $150K–$300K | 3.5x–4.0x | Owner performs 40%+ of billable hours, heavy Medicaid concentration, limited staff depth, or unresolved billing compliance exposure. |
| Stable / Owner-Operated | $300K–$600K | 4.0x–4.75x | 3–4 employed SLPs, moderate payer diversification, some owner clinical involvement, established local referral relationships. |
| Growing / Team-Based | $600K–$900K | 4.75x–5.5x | Owner largely administrative, 5+ SLPs, diversified payer mix, school contracts, documented referral pipelines, clean EHR and compliance history. |
| Premium / Platform-Ready | $900K+ | 5.5x–6.0x | Multi-location or telehealth capability, PE roll-up target, minimal owner clinical hours, recurring government contracts, strong retention metrics. |
Valuation Drivers — What Makes Your Multiple Higher or Lower
The spread between 3.5x and 6.5x is not random. These seven factors determine where your firm lands.
Owner Clinical Involvement
High NegativePractices where the founder generates more than 40% of billable revenue face steep discounts; buyers price in transition risk and potential patient attrition post-close.
Payer Mix Diversification
High PositiveA balanced mix of private insurance, direct-pay, and school district contracts reduces reimbursement risk. Heavy Medicaid concentration compresses multiples due to rate volatility.
SLP Staff Depth and Retention
High PositivePractices with 3–5+ employed SLPs holding independent patient relationships signal scalability and reduce key-person risk, directly supporting premium valuations.
Referral Source Durability
Moderate PositiveLong-standing school district contracts, ENT referrals, and pediatrician relationships tied to the practice entity — not the owner personally — are significant value drivers.
Billing Compliance and EHR Quality
Moderate NegativeUnresolved insurance audit exposure, outdated EHR systems, or poor HIPAA documentation create escrow holdbacks or price reductions during due diligence.
Recent Market Trends
PE-backed therapy platform consolidation accelerated in 2022–2024, compressing cap rates and pushing quality practices toward the upper end of the 5x–6x range. SBA 7(a) financing remains the dominant acquisition structure for individual SLP buyers. SLP workforce shortages are simultaneously pressuring margins and making staff-stable practices scarcer and more valuable to acquirers.
Who Buys Speech Therapy Practices in 2026
Individual Operator / Search Fund
Entrepreneurship through acquisition (ETA), first-time buyers, industry-adjacent operators
What they want: Stable, transferable cash flow in a Speech Therapy Practice. SBA-eligible business, strong payer mix diversification, and a seller available for a 12–18 month transition.
Pros for seller
- +SBA 7(a) financing means 10% buyer equity — faster than waiting for institutional capital
- +Buyer works inside the business, maintaining client and staff relationships
- +Deal structure is typically straightforward: cash at close plus seller note
Cons for seller
- −Lower multiples than PE buyers — typically at the low-to-mid end of the range
- −Requires meaningful seller involvement post-close for transition
- −SBA approval timeline adds 60–90 days to closing
PE-Backed Roll-Up Platform
Private equity consolidators building a Speech Therapy Practice portfolio, regional or national platforms
What they want: Scale, operational quality, and geographic coverage. Strong payer mix diversification with minimal owner clinical involvement. Clean financials, documented systems, and staff who can operate without the selling owner.
Pros for seller
- +All-cash close with no SBA financing contingency or approval delay
- +Highest multiples available for premium businesses
- +Equity rollover option — seller keeps 10–30% stake and participates in platform exit
Cons for seller
- −Extensive 90–150 day due diligence process
- −Post-close integration into a larger platform changes operating culture
- −Usually requires seller to remain in a leadership role for 12–24 months
Strategic Acquirer
Larger Speech Therapy Practice operators, adjacent-industry buyers adding capacity or geography
What they want: Client relationships, staff, and market position that complement existing operations. Payer Mix Diversification is especially valuable when it fills a gap the buyer cannot build organically.
Pros for seller
- +Can pay above-model multiples for strong strategic fit
- +Buyer already understands the business — diligence moves faster
- +Shorter transition requirement when operational overlap exists
Cons for seller
- −Fewer competing buyers — less negotiating leverage
- −Non-compete scope is typically broader than PE or individual deals
- −Operations and brand may change significantly post-close
Sample Speech Therapy Practice Transactions
Pediatric SLP clinic, Southeast U.S., 4 employed therapists, school district contracts, minimal owner caseload, diversified payer mix, clean compliance history.
$520,000
EBITDA
5.2x
Multiple
$2,704,000
Price
Single-location adult and pediatric practice, Midwest, owner performs 35% of billable hours, Medicaid-heavy payer mix, limited telehealth infrastructure.
$280,000
EBITDA
3.8x
Multiple
$1,064,000
Price
Multi-specialty outpatient therapy group with SLP division, 6 SLPs, two locations, recurring ENT and pediatrician referrals, strong waitlist demand.
$875,000
EBITDA
5.75x
Multiple
$5,031,250
Price
EBITDA Valuation Estimator
Get your Speech Therapy Practice business value range instantly
Industry: Speech Therapy Practice · Multiples based on 4.0x–4.75x (Stable / Owner-Operated)
Powered by DealFlow OS
dealflow-os.com · Free M&A tools for every stage of the deal
How to Use These Multiples
For Sellers: 4-Step Valuation Walkthrough
- 1
Compile three years of P&L statements and tax returns that reconcile line by line — SBA lenders and institutional buyers both require this, and any unexplained gap triggers diligence delays or price renegotiation.
- 2
Build a normalized EBITDA schedule with every add-back documented: owner W-2 above a market-rate manager salary, personal expenses, one-time items, and non-recurring costs. Undocumented add-backs get cut.
- 3
Address your owner clinical involvement before going to market — this is the most common reason Speech Therapy Practice businesses receive offers at the low end of the 3.5x–6x range. Buyers identify it in diligence and reprice accordingly.
- 4
Quantify and document your payer mix diversification with supporting records: contracts, renewal histories, and client revenue breakdowns. This is the primary evidence for commanding a premium multiple — have it ready before the first buyer call.
For Buyers: Validate the Asking Multiple
- 1
Request trailing 12-month and 3-year P&L with bank statement backup before making an offer. If a Speech Therapy Practice seller cannot produce reconciled financials, that signals what the full diligence process will look like.
- 2
Verify the payer mix diversification claims independently — pull contract copies, renewal documentation, and client-level revenue data. This is the primary driver of whether this Speech Therapy Practice is worth 6x or 3.5x.
- 3
Assess owner clinical involvement directly: ask which revenue or client relationships depend on the current owner personally, and what the transition plan is. An exit-ready seller has already worked through this.
- 4
Model your SBA debt service against verified EBITDA before signing the LOI. At current rates, a $1M SBA 7(a) loan runs approximately $13,000/month over 10 years — the business needs at least 1.25x debt service coverage after a market-rate manager salary.
Frequently Asked Questions
What EBITDA multiple should I expect when selling my speech therapy practice?
Most SLP practices in the $1M–$5M revenue range sell at 3.5x–6x EBITDA. Your specific multiple depends on owner independence, staff depth, payer mix, and referral source durability.
Why does owner clinical involvement reduce the sale price of an SLP practice?
Buyers price in revenue-at-risk when the founder holds the patient relationships. Reducing your personal caseload below 25% of practice revenue before selling materially improves your multiple.
Do speech therapy practices qualify for SBA financing?
Yes. SLP practices are SBA 7(a) eligible. Most deals involve 10–20% buyer equity, an SBA loan covering the majority of the purchase price, and a short-term seller note.
How does Medicaid concentration affect my speech therapy practice valuation?
Heavy Medicaid reliance introduces reimbursement rate risk and administrative burden, which buyers discount. Practices with under 30% Medicaid revenue and strong private-pay or school contracts command higher multiples.
More Speech Therapy Practice Guides
Related Reading
Find Speech Therapy Practice businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
No credit card required